FAP and neoplasm: Furthermore, this study showed that FAP-targeting is potentially superior to [18F]2-fluoro-2-deoxyglucose ([18F]FDG) in PET imaging for many important tumor entities, such as breast, lung, head-and-neck or colorectal cancers [6].